Orbit Research Assistive Technology Products and Study Determining At-Risk Populations For Glaucoma

Venkatesh Chari (Orbit Research - Wilmington, DE)

Dr. Josh Ehrlich (University of Michigan Kellogg Eye Center - Ann Arbor, MI)

Venkatesh Chari, Founder and CEO, of Orbit Research discusses various assistive technology products including the Orbit Player, the Orbit Speak, the Orbit Speak Plus, the Orbit Q20 Reader, and the Orbit Q40 Reader.

Then, Dr. Josh Ehrlich, Associate Professor of Ophthalmology and Visual Sciences, at the University of Michigan Kellogg Eye Center, explains a study that measured prevalence of glaucoma for specific at-risk groups based on race, gender, age, and geographic location.

 

4/27/2025 Podcast (Click Image Below)

iCare Home2 Tonometer and Creating Braille Tactile Labels On Clothing

Dr. Barbara Wirostko (University of Utah - Salt Lake City, UT)

University of Rhode Island (Kingston, RI)

Dr. Barbara Wirostko, Adjunct Professor Of Ophthalmology and Biomedical Engineering, John A. Moran Eye Center, University of Utah, Salt Lake City, Entrepreneur, Drug Developer, and Glaucoma Specialist, discusses the iCare Home2 Tonometer that glaucoma patients can use at home to monitor their eye pressure multiple times per day.

Dr. Izabela Ciesielska-Wrobel, Assistant Professor, Department of Textiles, Fashion Merchandising, and Design, College of Business, University of Rhode Island, Kingston, explains how 3D polyjet printing can be used to create braille tactile labels on clothing.

 4/13/2025 Podcast (Click Image Below)

Gene With Possible Links To Alzheimer's and Retinal Dysfunction and Valacyclovir To Treat Ocular Shingles

Dr. Ashay Bhatwadekar (Indiana University School of Medicine - Indianapolis, IN)

Dr. Bennie Jeng (University of Pennsylvania Penn Medicine - Philadelphia, PA)

Dr. Ashay Bhatwadekar, Associate Professor of Ophthalmology at the Indiana University School of Medicine in Indianapolis, discusses a gene, APOE4, that could be a possible link between Alzheimer's and retinal dysfunction.

Dr. Bennie Jeng, Chair of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Director of Scheie Eye Institute, Penn Medicine, explains how the drug, valacyclovir, could be a possible treatment for ocular shingles.

 4/6/2025 Podcast (Click Image Below)